Search
Sumario de resultados
TIpos de contenido
Fecha
-
Press releaseBiotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com...
There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and non-Hodgkin lymphoma. It is estimated that in 2024, around 12,400 new cases of
-
NewBiotechnology, at the forefront of the fight against sepsis, one of the world's most serio...
The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
-
Press release
Biotechnology, at the forefront of the fight against sepsis, one of the world's most serio...
Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to an infection, causing organ dysfunction. 22% of sepsis survivors who have
-
New#NewAseBioMember | “AseBio, for our small biotech, is a platform that offers a multitude o...
Meet Telomere Therapeutics, our new member. We spoke with Ana Margarita Maldonado, CMC & Regulatory Manager.
-
NewORYZON receives “Intention to grant” communication for patent relating to the use of vafid...
The intention to grant is a formal communication from the EPO in which it indicates that the patent application has reached the status where it is allowed for issuance as a patent.
-
NewBiological Sex Differences in Health: Challenges and Opportunities for Personalised Medici...
Biological sex should be considered as a variable in all health-related biomedical research.
-
NewIBRILATAZAR (ABTL0812) from AbilityPharma increases chemotherapy efectiveness by 40% in pa...
Ibrilatazar is an oral drug with a novel mechanism of acton that induces autophagy through the inducton of ER-stress and the inhibiton of the PI3K/Akt/mTOR pathway, which is crucial for cellular
-
NewORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadade...
Exploring the triple combination with venetoclax and azacitidine. Study sponsored by Oregon Health & Science University (OHSU).
-
NewBiotechnology Applied to Agriculture: Key to Addressing Challenges Such as Hunger, Climate...
The optimization of soil nutrient utilization, crops better adapted to climate change, or maximizing pest control through the digitalization of pesticide application are among the main areas of
-
Press release
Biotechnology Applied to Agriculture: Key to Addressing Challenges Such as Hunger, Climate...
The optimization of soil nutrient utilization, crops better adapted to climate change, or maximizing pest control through the digitalization of pesticide application are among the main areas of
-
NewBIOSPAIN 2023, finalist in the XIX edition of the Eventoplus Awards for "Best Congress"
The Eventoplus Awards are the most prestigious recognition in the events and meetings sector in Spain and Portugal, with the winners to be announced on September 17.
-
NewBioval holds session on bioeconomy and blue biotechnology and its General Assembly
On July 3rd we held the second General Assembly of the year and a bionetworking in the Veles e Vents building in Valencia together with all the associates.
-
NewORYZON continues to strengthen its patent portfolio for vafidemstat with additional “Decis...
In Australia, Malaysia and Mexico.
-
NewThe Organ-on-Chip Revolution: A Technology Enhancing Drug Development
Organ-on-Chip (OOC) technologies are an innovative approach that replicates human organ structures and functions on microfluidic platforms, providing detailed insights into complex physiological
-
NewNLRP3: From Scientific Curiosity to Therapeutic Efficacy
Joaquín Gómez Moya, executive president of Viva in Vitro, explains in this forum the important role of the NLRP3 inflammasome, popularly known as the “fashionable molecule”, crucial in the
-
NewBCN HEALTH publishes study on productivity losses due to lung cancer in Spain
Lung cancer was responsible for 69,225 deaths in the ten years of the study.
-
NewVaxdyn awarded €14.5 Million from the EIC Accelerator to Fund the Clinical Phase of Its Va...
The European Commission is committed to combating antibiotic resistance through vaccines, selecting Vaxdyn's competitive project. The entry into clinical phase of K-Vax, the vaccine against Klebsiella
-
-
New#NuevoSocioAseBio | “AseBio es el lugar perfecto para conectar con posibles colaboradores”
Meet Duponte, our new member. We spoke with Yolima Puentes, CEO.
-
NewEuropean researchers combine physics and biology to develop new biosensors
The result will be an ultra-sensitive biosensor based on DNA origami.
-
NewAlmirall launches Act4Impact – its updated sustainability strategy setting ambitious targe...
Act4Impact consists of 20 strategic lines of action which will be monitored over time to assess progress.
